Hengeler Mueller advises arrangers and underwriters on financing of planned acquisition of Sigma-Aldrich by Merck
22. September 2014
Merck, a leading company for high-tech products in the pharma, performance materials and life science sectors, and Sigma-Aldrich, also a leading life science and technology company, today announced that they have entered into a definitive agreement under which Merck will acquire Sigma-Aldrich for EUR 13.1 bn (converted). A USD 15.6 bn bridge financing has been secured for the all-cash transaction. The final financing structure will comprise a combination of cash on Merck’s balance sheet, bank loans and bonds. Deutsche Bank, J.P. Morgan and Société Générale acted as arrangers and underwriters in respect of the financing transaction. Closing is expected in mid-year 2015, subject to regulatory approvals, approval by a special shareholders' meeting of Sigma-Aldrich and other customary closing conditions.
Hengeler Mueller advised the arrangers and underwriters on the financing transaction. The Hengeler Mueller team included partners Thomas O. Cron, Nikolaus Vieten (both Financing), Counsel Mathias Link (Tax) (all Frankfurt) as well as associates Daniela Böning, Gunnar L. Schmüser and Andreas Lischka (all Financing, Frankfurt). US law aspects were covered in an integrated team with Cravath, Swaine & Moore, partner Joel F. Herold (London).